Evaluate the Predictive Impact of the EHMRG
EHMRGscore
1 other identifier
observational
1,500
0 countries
N/A
Brief Summary
External validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2022
CompletedFirst Posted
Study publicly available on registry
November 30, 2022
CompletedStudy Start
First participant enrolled
April 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedMarch 14, 2023
March 1, 2023
7 months
November 19, 2022
March 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EHMRGscore
The primary outcome of interest is the EHMRG predictive accuracy to prognosticate 7-day mortality was measured by the athe area under the receiver operating characteristic curver (AUROC) with 95% confidence intervals.
7days
Secondary Outcomes (2)
Re-admission rate 30-day re-admission rate
30days
Mortality rate Mortality rate at 30 days
30day
Study Arms (1)
EHMRGscore
validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department
Interventions
validation of the EHMRG score for hospitalized patients with acute heart failure in the emergency department
Eligibility Criteria
It is a prospective cohort study carried out in the ED of Monastir over a period from February 2009 to September 2020 which included patients admitted to the ED with a discharge diagnosis of AHF.
You may qualify if:
- Patients consulted for acute dyspnea and were diagnosed with acute heart failure.
- Major patient.
- Subject who accept to participate in the research.
You may not qualify if:
- Patient who refuse to participate in the study.
- Impossibility of giving the patient informed information
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Semir, Pr
University of Monastir
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical proffesor
Study Record Dates
First Submitted
November 19, 2022
First Posted
November 30, 2022
Study Start
April 30, 2023
Primary Completion
November 30, 2023
Study Completion
December 15, 2023
Last Updated
March 14, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
The EHMRG Risk score is based on commonly available parameters at presentation. It includes 10 predictors of mortality: age/mode of ED presentation / SBP / heart-rate / oxygen saturation/potassium concentration, creatinine concentration, troponin, presence of active cancer, and treatment with metolazone.